Cargando…

Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report

Tocilizumab, an interleukin-6 receptor antagonist, has been used to treat critically ill patients with coronavirus disease-2019. We present the case of a previously immunocompetent man with coronavirus disease-2019 who developed invasive pulmonary aspergillosis after treatment with tocilizumab, illu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witting, Celeste, Quaggin-Smith, Jessica, Mylvaganam, Ruben, Peigh, Graham, Angarone, Michael, Flaherty, James D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677089/ https://www.ncbi.nlm.nih.gov/pubmed/33388572 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115272

Ejemplares similares

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Tocilizumab: Invasive pulmonary aspergillosis and Escherichia coli infection due to off-label use: case report
Publicado: (2020)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022)

Air crescent sign: typical case of invasive pulmonary aspergillosis
por: Mayekar, Mrinmayee Vijay, et al.
Publicado: (2023)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

Pulmonary aspergillosis in an immunocompetent patient
por: Chien, Wei-Lun, et al.
Publicado: (2013)

The CT halo sign in invasive aspergillosis
por: Shroff, Sheetal, et al.
Publicado: (2014)

Characteristics of the Computed Tomography Imaging Findings in 72 Patients with Airway-Invasive Pulmonary Aspergillosis
por: Wu, Jing, et al.
Publicado: (2021)

Differences in Clinical Characteristics of Invasive Tracheobronchial Aspergillosis according to the Presence of Invasive Pulmonary Aspergillosis
por: Pak, Chuiyong, et al.
Publicado: (2021)

Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021)

Tocilizumab cost effective in reducing COVID-19-related deaths
Publicado: (2021)

Case report: Multimodality imaging of unusual coronary to pulmonary collaterals in chronic thromboembolic pulmonary hypertension
por: Goyal, Ansh, et al.
Publicado: (2023)

Invasive aspergillosis of pulmonary hydatid cyst
por: Nabi, Buzdar M. S., et al.
Publicado: (2009)

Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: Clinical presentation, risk factors, and outcomes
por: Zhang, Xuan, et al.
Publicado: (2017)

Clinical features and risk factors for viral pneumonia complicated with invasive pulmonary aspergillosis in adult patients
por: Li, Lijuan, et al.
Publicado: (2023)

Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia
por: David, Filipa, et al.
Publicado: (2022)

Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: to anti-coagulate or not?
por: Liu, Zhi-Bo, et al.
Publicado: (2019)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

Dapsone-induced neutropenia with invasive pulmonary aspergillosis
por: Sabnis, Girish R., et al.
Publicado: (2012)

Invasive Pulmonary Aspergillosis in an (Apparently) Immunocompetent Patient
por: Teixeira da Silva, Francisco, et al.
Publicado: (2020)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in a patient with cirrhosis
por: Clark, Heather L., et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in three cases of influenza
por: Selegatto, Glória, et al.
Publicado: (2022)

Invasive Pulmonary Aspergillosis Goes Viral Again?
por: Wauters, Joost, et al.
Publicado: (2021)

Neurological Involvement Complicating Invasive Pulmonary Aspergillosis
por: Diallo, Ibrahima Dokal, et al.
Publicado: (2022)

Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
por: Proesmans, M., et al.
Publicado: (2010)

Subacute invasive pulmonary aspergillosis after chemoradiotherapy for lung cancer
por: Watanabe, Hirofumi, et al.
Publicado: (2020)

Improvements in Intractable Lumbar and Lower-Extremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody
por: Sainoh, Takeshi, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
por: Tutar, Nuri, et al.
Publicado: (2013)

Coexistence of Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis
por: Naito, Maiko, et al.
Publicado: (2017)

Aspergillus Niger-pulmonary Aspergillosis in an Immunocompetent Woman
por: Otsuka, Rikako, et al.
Publicado: (2021)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
por: Conticini, Edoardo, et al.
Publicado: (2020)

Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome
por: Wu, Kuo-Lun, et al.
Publicado: (2022)

Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial
por: Xiao, Wei, et al.
Publicado: (2018)

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study
por: Melchers, Max, et al.
Publicado: (2022)

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
por: Chuang, Tzu-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4debad2qg3ido10viksce3qr2b